Established in 2000, the UC Center for Medicinal Cannabis Research (CMCR) has been at the forefront of advancing science and policy relating to the potential clinical benefits, and limitations, of cannabis and cannabinoids as medicine. The CMCR has conducted key studies regarding the short-term benefits of cannabis for the treatment of neuropathic pain and spasticity, and currently has an active, on-going program of research. Over the years the Center has established close and productive relationships with key Federal and State agencies, has significantly impacted policy, and remains a national leader in the field.
The mission of the CMCR is to accelerate high quality scientific studies intended to ascertain the medical safety and efficacy of cannabis and cannabinoid products and examine alternative forms of administration. More broadly, the CMCR is concerned with the health effects of cannabis. This includes advancing cannabinoid science via the awarding of grant funding, establishment of data and sample repositories, facilitating assessment and laboratory harmonization, and facilitating training of the next generation of researchers into cannabinoid science. The Center aims to be a model resource for health policy planning by virtue of its close collaboration with federal, state, and academic entities, as well as to act as a conduit for educating medical professionals and the public regarding the responsible use of cannabis/cannabinoids as medicine.